HTFL Heartflow, Inc.
Heartflow, Inc. (HTFL) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $2.2M.
Where they traded
Last open-market purchase: December 16, 2025 , by Lightcap Jeffrey C .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Rogers Campbell 3 fills | Chief Medical Officer | Sell 10b5-1 | 36,345 | $46.39 | $1.7M | 64,424 −36.1% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 38,900 | $55.74 | $2.2M | 251,983 −13.4% of holding | |
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 3,587 | $53.15 | $190.6K | 149,587 −2.3% of holding | |
| Rogers Campbell 3 fills | Chief Medical Officer | Sell 10b5-1 | 36,090 | $55.01 | $2.0M | 73,453 −32.9% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.